2018
DOI: 10.29145/sir/22/020201
|View full text |Cite
|
Sign up to set email alerts
|

A Study of Heart Enzyme Profile in Myocardial Infarction

Abstract: The work reported in this article was carried out to determine the role of cardiac enzymes in myocardial infarction. The cardiac enzyme levels of 30 normal subjects and 30 infarcted subjects were determined and compared by statistical analysis. The peak values of the statistical averages of CPK, AST and LDH were compared. The comparison indicated that the peak levels of cardiac enzymes in infarcted subjects were 1.5 to 6.1 times that of the normal subjects. The results also showed that the correlation between … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…In the past few years, the natural therapy has gained much attraction and attention for curing the cardiovascular and metabolic disorders as this therapy has fewer side effects. A study revealed that there is high occurrence of myocardial infarction in Islamic Republic of Pakistan with more than 30% of the inhabitants are being affected (> 45 years of age) by this disease (Meier et al, 2019, Khan et al, 2018. Doxorubicin (Dox) induced cardiomyopathy accounts for 1.7% to 6.8% in overall prevalence and is much dependent on gross dose (Skubitz et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…In the past few years, the natural therapy has gained much attraction and attention for curing the cardiovascular and metabolic disorders as this therapy has fewer side effects. A study revealed that there is high occurrence of myocardial infarction in Islamic Republic of Pakistan with more than 30% of the inhabitants are being affected (> 45 years of age) by this disease (Meier et al, 2019, Khan et al, 2018. Doxorubicin (Dox) induced cardiomyopathy accounts for 1.7% to 6.8% in overall prevalence and is much dependent on gross dose (Skubitz et al, 2017).…”
Section: Introductionmentioning
confidence: 99%